Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pacific Biosciences of California Inc.

www.pacificbiosciences.com

Latest From Pacific Biosciences of California Inc.

Illumina Aims For All-Inclusive Cancer Screen Via New Start-Up

Genetic sequencing company Illumina is betting it can develop the first next-generation sequencing "pan-cancer" screening assay by building a separate company dedicated to the task. The new firm has $100 million in start-up funds and is called Grail.

Medical Device Personalized Medicine

Device/Diagnostics Quarterly Deal Statistics, Q4 2014

Q4 device financing reached $902 million versus Q3’s $734 million, while device M&A dollar volume increased $19 billion, from Q3’s $4.9 billion. Diagnostics companies raised $750 million, an 85% rise over the previous quarter’s $405 million; although diagnostics M&A totaled just $1 billion, it was the most deal-active quarter of 2014 with 11 transactions.

Medical Device Deals

Start-Up Quarterly Statistics, Q4 2014

In Q4 2014 start-ups raised $1.5 billion, a new record. Several companies penned alliances with tech transfer entities; eight start-ups were acquired.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q2 2014

Device funding increased 123% to $1.6 billion in Q2, and M&A activity was overshadowed by Medtronic’s massive $47 billion acquisition of Covidien. Diagnostics fundraising dropped slightly to $522 million, and there were multiple takeovers of life sciences companies.

Medical Device Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
    • Pharmacogenetics-Pharmacogenomics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Nanofluidics Inc.
  • Pacific Biosciences Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pacific Biosciences of California Inc.
  • Senior Management
  • Michael W Hunkapiller, Pres. & CEO
    Susan K Barnes, CFO & EVP
    Michael Phillips, SVP, R&D
    Kathy Ordonez, EVP, Chief Commercial Officer
  • Contact Info
  • Pacific Biosciences of California Inc.
    Phone: (650) 521-8000
    1380 Willow Rd.
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register